The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
Open accessAbstract
We present the molecular landscape of pediatric acute myeloid leukemia (AML) and characterize nearly 1,000 participants in Children's Oncology Group (COG) AML trials. The COG–National Cancer Institute (NCI) TARGET AML initiative assessed cases by whole-genome, targeted DNA, mRNA and microRNA sequencing and CpG methylation profiling. Validated DNA variants corresponded to diverse, infrequent mutations, with fewer than 40 genes mutated in >2% of cases. In contrast, somatic structural variants, including new gene fusions and focal deletions of MBNL1, ZEB2 and ELF1, were disproportionately prevalent in young individuals as compared to adults. Conversely, mutations in DNMT3A and TP53, which were common in adults, were conspicuously absent from virtually all pediatric cases. New mutations in GATA2, FLT3 and CBL and recurrent mutations in MYC-ITD, NRAS, KRAS and WT1 were frequent in pediatric AML. Deletions, mutations and promoter DNA hypermethylation convergently impacted Wnt signaling, Polycomb repression, innate immune cell interactions and a cluster of zinc finger–encoding genes associated with KMT2A rearrangements. These results highlight the need for and facilitate the development of age-tailored targeted therapies for the treatment of pediatric AML.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Learning the parts of objects by non-negative matrix factorization
Lee, D. D., & Seung, H. S. (1999) · Nature · doi:10.1038/44565 · Cited by 13,868
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
Cingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Aryee, M. J., Jaffe, A. E., Corrada-Bravo, H., Ladd-Acosta, C., Feinberg, A. P., Hansen, K. D., & Irizarry, R. A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu049 · Cited by 4,397
Genomic classification and prognosis in acute myeloid leukemia
Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V. I., Paschka, P., Roberts, N. D., Potter, N. E., Heuser, M., Thol, F., Bolli, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516192 · Cited by 4,350
Camp, R. L., Dolled-Filhart, M., & Rimm, D. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0713 · Cited by 3,744
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Ye, K., Schulz, M. H., Long, Q., Apweiler, R., & Ning, Z. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp394 · Cited by 2,022
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Patel, J. P., Gönen, M., Figueroa, M. E., Fernandez, H., Sun, Z., Racevskis, J., Van Vlierberghe, P., Dolgalev, I., Thomas, S., Aminova, O., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112304 · Cited by 1,946
International incidence of childhood cancer, 2001–10: a population-based registry study
Steliarova-Foucher, E., Colombet, M., Ries, L. A. G., Moreno, F., Dolya, A., Bray, F., Hesseling, P., Shin, H. Y., Stiller, C. A., Bouzbid, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30186-9 · Cited by 1,757
Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs
Saunders, C. T., Wong, W. S. W., Swamy, S., Becq, J., Murray, L. J., & Cheetham, R. K. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts271 · Cited by 1,635
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Germline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345
Self-citationzoo : S3 Infrastructure for Regular and Irregular Time Series
Zeileis, A., & Grothendieck, G. (2005) · Journal of Statistical Software · doi:10.18637/jss.v014.i06 · Cited by 1,243
Human Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays
Drmanac, R., Sparks, A. B., Callow, M. J., Halpern, A. L., Burns, N. L., Kermani, B. G., Carnevali, P., Nazarenko, I., Nilsen, G. B., Yeung, G., et al. (2010) · Science · doi:10.1126/science.1181498 · Cited by 1,212
Cingolani, P., Patel, V. M., Coon, M., Nguyen, T., Land, S. J., Ruden, D. M., & Lu, X. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00035 · Cited by 1,064
De novo assembly and analysis of RNA-seq data
Robertson, G., Schein, J., Chiu, R., Corbett, R., Field, M., Jackman, S. D., Mungall, K., Lee, S., Okada, H. M., Qian, J. Q., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1517 · Cited by 998
Self-citationLow-level processing of Illumina Infinium DNA Methylation BeadArrays
Triche, T. J., Weisenberger, D. J., Van Den Berg, D., Laird, P. W., & Siegmund, K. D. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt090 · Cited by 905
Self-citationFunctional normalization of 450k methylation array data improves replication in large cancer studies
Fortin, J.-P., Labbe, A., Lemire, M., Zanke, B. W., Hudson, T. J., Fertig, E. J., Greenwood, C. M., & Hansen, K. D. (2014) · Genome Biology · doi:10.1186/s13059-014-0503-2 · Cited by 892
The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
Wang, Y., Krivtsov, A. V., Sinha, A. U., North, T. E., Goessling, W., Feng, Z., Zon, L. I., & Armstrong, S. A. (2010) · Science · doi:10.1126/science.1186624 · Cited by 763
A new method for constructing networks from binary data
van Borkulo, C. D., Borsboom, D., Epskamp, S., Blanken, T. F., Boschloo, L., Schoevers, R. A., & Waldorp, L. J. (2014) · Scientific Reports · doi:10.1038/srep05918 · Cited by 757
Burnett, A. K., Hills, R. K., Milligan, D., Kjeldsen, L., Kell, J., Russell, N. H., Yin, J. A. L., Hunter, A., Goldstone, A. H., & Wheatley, K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.4310 · Cited by 657
ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
Abdel-Wahab, O., Adli, M., LaFave, L. M., Gao, J., Hricik, T., Shih, A. H., Pandey, S., Patel, J. P., Chung, Y. R., Koche, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.032 · Cited by 599
Gamis, A. S., Alonzo, T. A., Meshinchi, S., Sung, L., Gerbing, R. B., Raimondi, S. C., Hirsch, B. A., Kahwash, S. B., Heerema-McKenney, A., Winter, L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.3628 · Cited by 486
Self-citationMiller, C. A., White, B. S., Dees, N. D., Griffith, M., Welch, J. S., Griffith, O. L., Vij, R., Tomasson, M. H., Graubert, T. A., Walter, M. J., et al. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003665 · Cited by 454
MicroRNA Expression in Cytogenetically Normal Acute Myeloid Leukemia
Marcucci, G., Radmacher, M. D., Maharry, K., Mrózek, K., Ruppert, A. S., Paschka, P., Vukosavljevic, T., Whitman, S. P., Baldus, C. D., Langer, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074256 · Cited by 441
Exploring genomic alteration in pediatric cancer using ProteinPaint
Zhou, X., Edmonson, M. N., Wilkinson, M. R., Patel, A., Wu, G., Liu, Y., Li, Y., Zhang, Z., Rusch, M. C., Parker, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3466 · Cited by 392
Self-citationDistinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
Li, S., Garrett-Bakelman, F. E., Chung, S. S., Sanders, M. A., Hricik, T., Rapaport, F., Patel, J., Dillon, R., Vijay, P., Brown, A. L., et al. (2016) · Nature Medicine · doi:10.1038/nm.4125 · Cited by 387
Hollink, I. H. I. M., van den Heuvel-Eibrink, M. M., Arentsen-Peters, S. T. C. J. M., Pratcorona, M., Abbas, S., Kuipers, J. E., van Galen, J. F., Beverloo, H. B., Sonneveld, E., Kaspers, G.-J. J. L., et al. (2011) · Blood · doi:10.1182/blood-2011-04-346643 · Cited by 334
Self-citationTreatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials
Gibson, B. E. S., Wheatley, K., Hann, I. M., Stevens, R. F., Webb, D., Hills, R. K., De Graaf, S. S. N., Harrison, C. J., & for the United Kingdom Childhood Leukaemia Working Party, A. T. D. C. O. G. (2005) · Leukemia · doi:10.1038/sj.leu.2403924 · Cited by 303
Gruber, T. A., Larson Gedman, A., Zhang, J., Koss, C. S., Marada, S., Ta, H. Q., Chen, S.-C., Su, X., Ogden, S. K., Dang, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.007 · Cited by 283
Self-citationLange, B. J., Smith, F. O., Feusner, J., Barnard, D. R., Dinndorf, P., Feig, S., Heerema, N. A., Arndt, C., Arceci, R. J., Seibel, N., et al. (2008) · Blood · doi:10.1182/blood-2007-04-084293 · Cited by 274
Self-citationThe genomic landscape of core-binding factor acute myeloid leukemias
Faber, Z. J., Chen, X., Gedman, A. L., Boggs, K., Cheng, J., Ma, J., Radtke, I., Chao, J.-R., Walsh, M. P., Song, G., et al. (2016) · Nature Genetics · doi:10.1038/ng.3709 · Cited by 269
Self-citationGöllner, S., Oellerich, T., Agrawal-Singh, S., Schenk, T., Klein, H.-U., Rohde, C., Pabst, C., Sauer, T., Lerdrup, M., Tavor, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4247 · Cited by 257
Guryanova, O. A., Shank, K., Spitzer, B., Luciani, L., Koche, R. P., Garrett-Bakelman, F. E., Ganzel, C., Durham, B. H., Mohanty, A., Hoermann, G., et al. (2016) · Nature Medicine · doi:10.1038/nm.4210 · Cited by 256
CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer
Leiserson, M. D., Wu, H.-T., Vandin, F., & Raphael, B. J. (2015) · Genome Biology · doi:10.1186/s13059-015-0700-7 · Cited by 210
Pession, A., Masetti, R., Rizzari, C., Putti, M. C., Casale, F., Fagioli, F., Luciani, M., Lo Nigro, L., Menna, G., Micalizzi, C., et al. (2013) · Blood · doi:10.1182/blood-2013-03-491621 · Cited by 202
Cooper, T. M., Franklin, J., Gerbing, R. B., Alonzo, T. A., Hurwitz, C., Raimondi, S. C., Hirsch, B., Smith, F. O., Mathew, P., Arceci, R. J., et al. (2012) · Cancer · doi:10.1002/cncr.26190 · Cited by 199
Self-citationCreutzig, U., Zimmermann, M., Lehrnbecher, T., Graf, N., Hermann, J., Niemeyer, C. M., Reiter, A., Ritter, J., Dworzak, M., Stary, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5037 · Cited by 194
The role of the GATA2 transcription factor in normal and malignant hematopoiesis
Vicente, C., Conchillo, A., García-Sánchez, M. A., & Odero, M. D. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.04.007 · Cited by 175
Hollink, I. H. I. M., Zwaan, C. M., Zimmermann, M., Arentsen-Peters, T. C. J. M., Pieters, R., Cloos, J., Kaspers, G. J. L., de Graaf, S. S. N., Harbott, J., Creutzig, U., et al. (2009) · Leukemia · doi:10.1038/leu.2008.313 · Cited by 166
Self-citationFarrar, J. E., Schuback, H. L., Ries, R. E., Wai, D., Hampton, O. A., Trevino, L. R., Alonzo, T. A., Guidry Auvil, J. M., Davidsen, T. M., Gesuwan, P., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1015 · Cited by 163
Self-citationde Hoon, M., Taft, R. J., Hashimoto, T., Kanamori-Katayama, M., Kawaji, H., Kawano, M., Kishima, M., Lassmann, T., Faulkner, G. J., Mattick, J. S., et al. (2010) · Genome Research · doi:10.1101/gr.095273.109 · Cited by 153
Valencia, A., Román‐Gómez, J., Cervera, J., Such, E., Barragán, E., Bolufer, P., Moscardó, F., Sanz, G. F., & Sanz, M. Á. (2009) · Leukemia · doi:10.1038/leu.2009.86 · Cited by 149
Chun, H.-J. E., Lim, E. L., Heravi‐Moussavi, A., Saberi, S., Mungall, K., Bilenky, M., Carles, A., Tse, K., Shlafman, I., Zhu, K., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.02.009 · Cited by 147
Self-citationOstronoff, F., Othus, M. K. D., Gerbing, R. B., Loken, M. R., Raimondi, S. C., Hirsch, B. A., Lange, B. J., Petersdorf, S. H., Radich, J. P., Appelbaum, F. R., et al. (2014) · Blood · doi:10.1182/blood-2014-04-570929 · Cited by 146
Self-citationMayakonda, A., & Koeffler, H. P. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/052662 · Cited by 138
Ho, P. A., Kutny, M. A., Alonzo, T. A., Gerbing, R. B., Joaquin, J., Raimondi, S. C., Gamis, A. S., & Meshinchi, S. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23179 · Cited by 123
Self-citationBalgobind, B. V., Hollink, I. H. I. M., Arentsen-Peters, S. T. C. J. M., Zimmermann, M., Harbott, J., Beverloo, H. B., von Bergh, A. R. M., Cloos, J. J., Kaspers, G. J. L., de Haas, V., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.038976 · Cited by 123
Self-citationTherapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia
Liang, K., Volk, A. G., Haug, J. S., Marshall, S. A., Woodfin, A. R., Bartom, E. T., Gilmore, J. M., Florens, L. A., Washburn, M. P., Sullivan, K. D., et al. (2017) · Cell · doi:10.1016/j.cell.2016.12.011 · Cited by 123
Self-citationGoossens, S., Janzen, V., Bartunkova, S., Yokomizo, T., Drogat, B., Crisan, M., Haigh, K., Seuntjens, E., Umans, L., Riedt, T., et al. (2011) · Blood · doi:10.1182/blood-2010-08-300236 · Cited by 113
Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations
Loghavi, S., Zuo, Z., Ravandi, F., Kantarjian, H. M., Bueso-Ramos, C., Zhang, L., Singh, R. R., Patel, K. P., Medeiros, L. J., Stingo, F. C., et al. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0074-4 · Cited by 107
Goossens, S., Radaelli, E., Blanchet, O., Durinck, K., der Meulen, J. V., Peirs, S., Taghon, T., Tremblay, C. S., Costa, M., Ghahremani, M. F., et al. (2015) · Nature Communications · doi:10.1038/ncomms6794 · Cited by 94
DNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression
Wang, Y., Kamarova, Y., Shen, K. C., Jiang, Z., Hahn, M., Wang, Y., & Brooks, S. C. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.10.2073 · Cited by 91
Regression Models for Multivariate Count Data
Zhang, Y., Zhou, H., Zhou, J. J., & Sun, W. (2016) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.2016.1154063 · Cited by 88
Li, J., Riedt, T., Goossens, S., García, C. C., Szczepanski, S., Brandes, M., Pieters, T., Dobrosch, L., Gütgemann, I., Farla, N., et al. (2016) · Blood · doi:10.1182/blood-2016-05-714659 · Cited by 77
Nanbakhsh, A., Pochon, C., Mallavialle, A., Amsellem, S., Bourhis, J. H., & Chouaïb, S. (2014) · Blood · doi:10.1182/blood-2013-11-536219 · Cited by 72
Sinha, S., Thomas, D., Yu, L. C., Gentles, A. J., Jung, N., Corces, M. R., Chan, S. M., Reinisch, A., Feinberg, A. P., Dill, D. L., et al. (2014) · Blood · doi:10.1182/blood-2014-03-566018 · Cited by 61
Xu, B., Zeng, D., Wu, Y., Zheng, R. Q., Gu, L., Lin, X., Hua, X., & Jin, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.197830 · Cited by 42
Negative regulation of TIM-3 expression in AML cell line (HL-60) using miR-330-5p
Fooladinezhad, H., Khanahmad, H., Ganjalıkhani-Hakemi, M., & Doosti, A. (2016) · British Journal of Biomedical Science · doi:10.1080/09674845.2016.1194564 · Cited by 36
Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis
Bustamante, O. Q., Smith, S. L.-L., Griessinger, E., Reyal, Y., Vargaftig, J., Lister, T. A., Fitzgibbon, J., & Bonnet, D. A. (2012) · Leukemia · doi:10.1038/leu.2012.38 · Cited by 28
Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1
Xiang, P., Lo, C., Argiropoulos, B., Lai, C. B., ROUHI, A. M., Imren, S., Jiang, X., Mager, D. L., & Humphries, R. K. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.06.006 · Cited by 27
Runx1 deficiency permits granulocyte lineage commitment but impairs subsequent maturation
Ng, K. P., Hu, Z., Ebrahem, Q., Negrotto, S., Lausen, J., & Saunthararajah, Y. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.41 · Cited by 27
Ramamurthy, R., Hughes, M., Morris, V., Bolouri, H., Gerbing, R. B., Wang, Y., Loken, M. R., Raimondi, S. C., Hirsch, B. A., Gamis, A. S., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26157 · Cited by 27
Self-citationCaudell, D. L., Harper, D. P., Novak, R. L., Pierce, R. M., Slape, C. I., Wolff, L., & Aplan, P. D. (2009) · Blood · doi:10.1182/blood-2009-04-216184 · Cited by 25
Cited by
Neoantigens: promising targets for cancer therapy
Xie, N., Shen, G., Gao, W., Huang, Z., Huang, C., & Fu, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01270-x · Cited by 1,020
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
Ma, X., Liu, Y., Liu, Y., Alexandrov, L. B., Edmonson, M. N., Gawad, C., Zhou, X., Li, Y., Rusch, M. C., Easton, J., et al. (2018) · Nature · doi:10.1038/nature25795 · Cited by 901
Self-citationClonal Hematopoiesis and Evolution to Hematopoietic Malignancies
Bowman, R. L., Busque, L., & Levine, R. L. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.01.011 · Cited by 448
Shen, C., Sheng, Y., Zhu, A. C., Robinson, S., Jiang, X., Dong, L., Chen, H., Su, R., Yin, Z., Li, W., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.04.009 · Cited by 373
The genetic basis and cell of origin of mixed phenotype acute leukaemia
Alexander, T. B., Gu, Z., Iacobucci, I., Dickerson, K., Choi, J. K., Xu, B., Payne-Turner, D., Yoshihara, H., Loh, M. L., Horan, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0436-0 · Cited by 367
Self-citation
Metadata
- Authors
- Bolouri, H., Farrar, J. E., Triche, T., Ries, R. E., Lim, E. L., Alonzo, T. A., Ma, Y., Moore, R., Mungall, A. J., Marra, M. A., Zhang, J., Ma, X., Liu, Y., Liu, Y., Guidry Auvil, J. M., Davidsen, T. M., Gesuwan, P., Hermida, L. C., Salhia, B., Capone, S., Ramsingh, G., Zwaan, C. M., Noort, S., Piccolo, S. R., Kolb, E. A., Gamis, A. S., Smith, M. A., Gerhard, D. S., & Meshinchi, S.
- Venue
- Nature Medicine
- Published
- 2017-12-11
- Volume
- 24
- Issue
- 1
- Pages
- 103-112
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2773514102
- Cited by
- 848
- References
- 73
- FWCI
- 32.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.